Palantir Shares Fall as Earnings Miss Elevated Expectations

Published 1 hours agoPLTR

Palantir Shares Fall as Earnings Miss Elevated Expectations

Palantir Technologies saw its stock slip roughly 7% in premarket trading after its recent earnings report failed to meet the high expectations held by investors. Despite a raised full-year forecast, the results did not provide the substantial gains that the market anticipated, causing immediate reactions in the stock price. Reuters reported this decline highlighted investor dissatisfaction, despite an upward revision in revenue projections.

In the report, Palantir revealed a 39% increase in total revenue to $883.9 million year-over-year, with U.S. government revenue jumping 45%. The company adjusted its full-year revenue forecast to a range of $3.89 billion to $3.90 billion from the previous estimate of $3.74 billion to $3.76 billion. While these figures surpassed expectations, they were not enough to soothe investor concerns.

Analyst insights point to valuation issues as a significant concern. With a forward price-to-earnings ratio of 202.07, Palantir's valuation overshadows competitors like Snowflake, Salesforce, and Datadog. Morningstar analyst Mark Giarelli commented on the challenges of investor expectations, noting that strong earnings beats and guidance increases are insufficient to drive the stock higher. These concerns reflect in the potential market valuation loss exceeding $19 billion if the premarket trends continue.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Constellation Energy Rides AI Project Wave, Acquires Calpine

Constellation Energy Rides AI Project Wave, Acquires Calpine

6 minutes agoCEG

Constellation Energy's stock has experienced a notable surge as investors rally around the firm’s strategic initiatives in AI data center power projects and gain optimism from upcoming nuclear deals. The energy giant is pivoting to supplying AI data centers with power through grid-connected solutions—a move driven by regulatory hurdles in co-located projects, reported Reuters. This approach is designed to enhance grid reliability and manage costs more efficiently. A major development fueling this optimism is the $27 billion acquisition of Calpine Corporation, which significantly strengthens Constellation Energy’s market position. This merger combines two major U.S. electricity generators, aiming to meet the rising power demand spurred by AI advancements, serving about 2.5 million customers. Furthermore, Constellation is investing $1.6 billion to reactivate the Three Mile Island nuclear plant, which will deliver 835 megawatts of electricity to help satiate the growing needs of AI-driven technologies, specifically for Microsoft’s data centers. Constellation Energy's share price recently stood at 259.2 USD, marking a 10.93 USD increase, reflecting a modest gain amid these strategic moves. According to Reuters, this boost comes on the back of strategic decisions and partnerships that underline the company's commitment to expanding its role in AI infrastructure. Analysts and stakeholders have responded favorably to these initiatives, aligning with the company’s vision for a more sustainable and technologically integrated future.

Vertex Pharmaceuticals Shares Dip After Earnings Miss Expectations

Vertex Pharmaceuticals Shares Dip After Earnings Miss Expectations

21 minutes agoVRTX

Vertex Pharmaceuticals saw its stock decline after reporting first-quarter 2025 earnings that fell short of expectations. The company reported an adjusted profit of $4.06 per share, missing analyst estimates of $4.32, as noted by Reuters. Coupled with this, total quarterly revenue rose 2.7% to $2.77 billion, which was below the anticipated $2.85 billion. Sales of Trikafta, its flagship cystic fibrosis drug, increased 2% year-over-year to $2.53 billion, but did not meet forecasts of $2.58 billion. This contributed to a 2.5% drop in Vertex's stock price during after-hours trading. Despite these challenges, the company raised its 2025 revenue forecast's lower end to between $11.85 billion and $12 billion. Vertex has been actively expanding its portfolio, launching the non-opioid pain medication Journavx in March, quickly gaining traction with over 20,000 prescriptions. Furthermore, the company reports advances with its gene therapy Casgevy for rare blood disorders, having activated more than 65 treatment centers and initiating cell collection for 90 patients.

Investor Maintains Caution on Apple Amid Tariff and Valuation Concerns

Investor Maintains Caution on Apple Amid Tariff and Valuation Concerns

36 minutes agoAAPL

A veteran investor remains neutral on Apple Inc. (AAPL) stock, citing recent challenges that could impact the tech giant's financial performance. The primary concern revolves around new tariffs imposed by the U.S. government, which might squeeze Apple's profit margins, potentially making the stock less appealing compared to previous quarters, as reported by thestreet.com. In addition to the tariff issues, the investor points to Apple's current high price-to-earnings (P/E) ratio. This measure suggests that the stock might be overvalued, leading to potential hesitation among some investors. Despite these concerns, as of May 6, 2025, Apple's shares are trading at $198.09, marking a minor decrease of 0.4% from the previous trading session. The cautious stance reflects broader uncertainties affecting Apple's market performance, with current trading figures showing a slight dip. The stock opened at $198.18, with an intraday range of $197.06 to $198.41, and a trading volume of 6,117,425 shares as noted in recent data. These dynamics underscore the investor's careful watch on both market conditions and Apple's strategic adjustments moving forward.

Lucid Group CEO Departure and Strong Q4 Deliveries Shake Up EV Market

Lucid Group CEO Departure and Strong Q4 Deliveries Shake Up EV Market

51 minutes agoLCID

Lucid Group, a well-known luxury electric vehicle manufacturer, is making headlines following the unexpected departure of its CEO, Peter Rawlinson. Marc Winterhoff has been appointed as the interim CEO, according to Reuters. This leadership change comes amidst ongoing speculation about the company's future positioning in the automobile market. The company reported a robust financial performance for the fourth quarter of 2024, delivering 3,099 vehicles and exceeding analyst expectations of 2,637. This marks a significant annual increase of 71% in deliveries, with a total of 10,241 vehicles supplied throughout the year. Additionally, Lucid has expanded its product portfolio by launching the Lucid Gravity SUV, which boasts a starting price of $94,900 and an impressive EPA-rated range of up to 450 miles. Despite these positive developments, Lucid's stock performance remains a concern for investors. Currently trading at $2.36 on the stock market, the company's shares have seen a 96% decline from their 2021 peak. Furthermore, Lucid closed 2024 with around $5.08 billion in cash, offering a financial runway into 2026. However, analysts have given a "Hold" rating with an average price target of $2.69, indicating limited projected growth potential.